Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.145 CAD | +16.00% | +11.54% | -6.45% |
Apr. 02 | Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 16 | Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer | CI |
Sales 2022 | 37.18 50.73 | Sales 2023 | 0.69 0.94 | Capitalization | 390K 532K |
---|---|---|---|---|---|
Net income 2022 | -18M -24.56M | Net income 2023 | -16M -21.83M | EV / Sales 2022 | 22,108 x |
Net cash position 2022 | 2.64M 3.61M | Net Debt 2023 | 665K 907K | EV / Sales 2023 | 1,537,011 x |
P/E ratio 2022 |
-0.19
x | P/E ratio 2023 |
-0.02
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 95.78% |
1 day | +16.00% |
Managers | Title | Age | Since |
---|---|---|---|
David Preiner
CEO | Chief Executive Officer | - | 21-04-29 |
Evan Veryard
IRC | Investor Relations Contact | - | - |
1st Jan change | Capi. | |
---|---|---|
+3.41% | 32.18B | |
+14.79% | 7.33B | |
+20.38% | 3.83B | |
-14.26% | 3.23B | |
-27.90% | 1.25B | |
-34.43% | 1.12B | |
+2.01% | 912M | |
-24.21% | 856M | |
-38.47% | 859M |
- Stock Market
- Equities
- MEDVF Stock
- CUO Stock